federal_register: 00-10456
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 00-10456 | Over-the-Counter Drug Products; Public Hearing | Notice | The Food and Drug Administration (FDA) is announcing a public hearing about the agency's approach to regulating over-the-counter (OTC) drug products. The purpose of the hearing is to solicit information from, and the views of, interested persons, including scientists, professional groups, and consumers. FDA intends to elicit comment on general issues regarding the status of OTC drug products, including the criteria the agency should consider in rendering decisions on OTC availability of drugs, the classes of products, if any, that are not currently available OTC that should or should not be available OTC, how FDA can be assured that consumers understand the issues relating to OTC availability of drug products, how rational treatment decisions are affected by coexisting prescription and OTC therapies for a given disease, whether the current structure for marketing OTC products in the United States is adequate, and FDA's role in switching products from prescription to OTC status. | 2000-04-27 | 2000 | 4 | https://www.federalregister.gov/documents/2000/04/27/00-10456/over-the-counter-drug-products-public-hearing | https://www.govinfo.gov/content/pkg/FR-2000-04-27/pdf/00-10456.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing a public hearing about the agency's approach to regulating over-the-counter (OTC) drug products. The purpose of the hearing is to solicit information from, and the views of, interested persons,... |